688036:SSEShenzhen Transsion Holding Co., Ltd. Class A Analysis
Data as of 2026-05-17 - not real-time
CN¥60.70
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Shenzhen Transsion Holdings is trading at CNY 60.7, comfortably above its 20‑day SMA (56.54) but still below the 200‑day SMA (69.46), indicating a neutral longer‑term trend. The stock’s PE ratio of 24.98 is well under the industry average of 38.63, while the forward PE of 10.45 suggests future earnings could be substantially higher. Momentum indicators are mixed: the RSI of 65.5 points to mild overbought conditions, yet the MACD histogram (+0.44) remains bullish, and volume is stable.
Revenue is expanding rapidly at 24.6% YoY, but profitability is thin with a gross margin of 19.4% and operating cash flow that is negative, raising concerns about the sustainability of the 3.79% dividend yield given a payout ratio near 95%. The stock’s beta of -0.27 and 30‑day volatility of 35.8% imply heightened price swings, while the support level at CNY 51.7 and resistance at CNY 62.46 frame the near‑term price range.
Revenue is expanding rapidly at 24.6% YoY, but profitability is thin with a gross margin of 19.4% and operating cash flow that is negative, raising concerns about the sustainability of the 3.79% dividend yield given a payout ratio near 95%. The stock’s beta of -0.27 and 30‑day volatility of 35.8% imply heightened price swings, while the support level at CNY 51.7 and resistance at CNY 62.46 frame the near‑term price range.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD despite overbought RSI
- Price near resistance at CNY 62.46
- Stable trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth of 24.6% YoY
- Undervalued relative to industry PE
- Attractive dividend yield
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Expanding presence in emerging markets
- Negative operating and free cash flow
- Potential regulatory headwinds in China tech sector
Key Metrics & Analysis
Financial Health
Revenue Growth24.60%
Profit Margin4.06%
P/E Ratio25.0
ROE13.48%
ROA4.25%
Debt/Equity18.04
P/B Ratio3.3
Op. Cash FlowCN¥-1933216000
Free Cash FlowCN¥-4232210944
Industry P/E38.6
Technical Analysis
TrendNeutral
RSI65.5
SupportCN¥51.70
ResistanceCN¥62.46
MA 20CN¥56.54
MA 50CN¥55.37
MA 200CN¥69.46
MACDBullish
VolumeStable
Fear & Greed Index88.52
Valuation
GradeUndervalued
TypeBlend
Dividend Yield3.79%
Risk Assessment
Beta-0.27
Volatility35.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.